Tag results:
PI3K
Dermal Cell News
High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma
[Journal of Natural Products] An in-house library of 2576 plant extracts was screened on two melanoma cell lines with different oncogenic mutations leading to pathological ERK/AKT activity.
Mammary Cell News
EIF4A3-Mediated CircPRKCI Expression Promotes Triple-Negative Breast Cancer Progression by Regulating WBP2 and PI3K/AKT Signaling Pathway
[Cell Death Discovery] Researchers demonstrated that circular RNA PRKCI (circPRKCI), derived from the PRKCI gene, was elevated in breast cancer tissues and cell lines, especially in TNBC.
Cancer Stem Cell News
Extracellular ATP Promotes Breast Cancer Chemoresistance via HIF-1α Signaling
[Cell Death & Disease] The authors reported that hypoxia-inducible factor 1α (HIF-1α) was upregulated after ATP treatment and mediated the ATP-driven chemoresistance process.
Hepatic Cell News
Downregulation of MUC15 by miR-183-5p.1 Promotes Liver Tumor-Initiating Cells Properties and Tumorigenesis via Regulating C-MET/PI3K/AKT/SOX2 Axis
[Cell Death & Disease] Researchers reported that expression of mucin 15 (MUC15) was downregulated in liver tumor-initiating cells, chemoresistance, and recurrent HCC samples.
Pancreatic Cell News
Lucidone Inhibits Autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt Signaling Pathway in Pancreatic Cancer Cells
[Phytotherapy Research] Investigators explored the function of lucidone in tumor cytotoxicity and chemosensitivity through the suppression of receptor for advanced glycation end products-initiated signaling in pancreatic ductal adenocarcinoma cells.
Prostate Cell News
PI3K-Regulated Glycine N-Methyltransferase Is Required for the Development of Prostate Cancer
[Oncogenesis] Researchers integrated human studies, genetic mouse modeling, and cellular systems to characterize the regulation and function of glycine N-Methyltransferase in prostate cancer.